TTNP - TITAN PHARMACEUTICALS INC
4.61
-0.180 -3.905%
Share volume: 3,358,220
Last Updated: 10-01-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$4.79
-0.18
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | |
| Report Date | 05-15-2024 | 08-15-2024 | 01-03-2025 | 03-20-2025 | 05-14-2025 | 08-14-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | ||||
| Operating expenses | 1.063 M | 2.074 M | 754.000 K | 666.000 K | 534.000 K | 657.000 K | |
| Selling general and admin | 1.063 M | 2.074 M | 754.000 K | 666.000 K | 534.000 K | 657.000 K | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 1.063 M | 2.074 M | 754.000 K | 666.000 K | 534.000 K | 657.000 K | |
| 95.11% | -63.65% | -11.67% | -19.82% | 23.03% | |||
| Operating income | -1.063 M | -2.074 M | -754.000 K | -666.000 K | -534.000 K | -657.000 K | |
| Ebit | -1.065 M | -2.093 M | -763.000 K | -786.000 K | -563.000 K | -689.000 K | |
| Pretax income | -1.064 M | -2.093 M | -763.000 K | -786.000 K | -563.000 K | -689.000 K | |
| 96.71% | -63.55% | 3.01% | -28.37% | 22.38% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -1.060 M | -2.093 M | -763.000 K | -790.000 K | -563.000 K | -689.000 K | |
| -97.45% | 63.55% | -3.54% | 28.73% | -22.38% |